Rentokil Initial (RTO) EBIT (2021 - 2025)

Rentokil Initial (RTO) has 4 years of EBIT data on file, last reported at $510.0 million in Q4 2025.

• On a quarterly basis, EBIT changed N/A year-over-year to $510.0 million in Q4 2025; TTM through Dec 2025 was $1.5 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 52.47% from the prior year.
• EBIT for Q4 2025 stood at $510.0 million, up from -$230.0 million in the prior quarter.
• Over the last five years, EBIT for RTO reached as high as $669.7 million in Q4 2022 and fell as low as -$230.0 million in Q3 2025.
• Historically, EBIT has averaged $417.6 million across 4 years, with a median of $542.4 million in 2023.
• Across the five-year window, EBIT rose 12.41% in 2022 and decreased 19.02% in 2023, its largest moves.
• Year by year, EBIT stood at $595.8 million in 2021, then rose by 12.41% to $669.7 million in 2022, then declined by 19.02% to $542.4 million in 2023, then fell by 5.97% to $510.0 million in 2025.
• Per Business Quant data, the three most recent EBIT figures were $510.0 million in Q4 2025, -$230.0 million in Q3 2025, and $542.4 million in Q4 2023.